Turner Christopher Durant
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Turner Christopher Durant. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NUVL | Chief Medical Officer | Award / Grant | 18,750 | — | — | Jan 6, 2025 |
| NUVL | Chief Medical Officer | Award / Grant | 33,300 | — | — | Jan 5, 2024 |
| NUVL | Chief Medical Officer | Sale | 600 | $54.32 | $32,592 | Oct 4, 2023 |
| NUVL | Chief Medical Officer | Sale | 2,665 | $48.93 | $130,398 | Jul 28, 2023 |
| NUVL | Chief Medical Officer | Sale | 200 | $46.82 | $9,364 | Jul 20, 2023 |
| NUVL | Chief Medical Officer | Sale | 10,235 | $44.86 | $459,142 | Jun 5, 2023 |
| NUVL | Chief Medical Officer | Option Exercise | 14,513 | $6.89 | $99,995 | May 17, 2022 |